| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 6, 2791-2799, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
MD Brown, AS Voljavec, MT Lott, I MacDonald and DC Wallace
Department of Genetics and Molecular Medicine, Emory University School of Medicine, Atlanta, Georgia 30322.
A number of human diseases have been attributed to defects in oxidative phosphorylation (OXPHOS) resulting from mutations in the mitochondrial DNA (mtDNA). One such disease is Leber's hereditary optic neuropathy (LHON), a neurodegenerative disease of young adults that results in blindness due to atrophy of the optic nerve. The etiology of LHON is genetically heterogeneous and in some cases multifactorial. Eleven mtDNA mutations have been associated with LHON, all of which are missense mutations in the subunit genes for the subunits of the electron transport chain complexes I, III, and IV. Molecular, biochemical, and population genetic studies have categorized these mutations as high risk (class I), low risk (class II), or intermediate risk (class I/II). Class I mutations appear to be primary genetic causes of LHON, while class II mutations are frequently found associated with class I genotypes and may serve as exacerbating genetic factors. Different LHON pedigrees can harbor different combinations of class I, II, or I/II mtDNA mutations, as shown by the complete sequence analysis of the mtDNAs of four LHON probands. The various mtDNA genotypes included an isolated class I mutation, combined class I+II mutations, and combined class I/II+II mutations. The occurrence of such genotypes supports the hypothesis that LHON may result from the additive effects of various genetic and environmental insults to OXPHOS, each of which increases the probability of blindness.
This article has been cited by other articles:
|
|
 |
|
  W.-K. Ju, Q. Liu, K.-Y. Kim, J. G. Crowston, J. D. Lindsey, N. Agarwal, M. H. Ellisman, G. A. Perkins, and R. N. Weinreb Elevated Hydrostatic Pressure Triggers Mitochondrial Fission and Decreases Cellular ATP in Differentiated RGC-5 Cells Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2145 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Atilano, P. Coskun, M. Chwa, N. Jordan, V. Reddy, K. Le, D. C. Wallace, and M. C. Kenney Accumulation of Mitochondrial DNA Damage in Keratoconus Corneas Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1256 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Qi, A. S. Lewin, W. W. Hauswirth, and J. Guy Optic Neuropathy Induced by Reductions in Mitochondrial Superoxide Dismutase Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1088 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-J. C. Wong, M.-H. Liang, H. Kwon, J. Park, R.-K. Bai, and D.-J. Tan Comprehensive Scanning of the Entire Mitochondrial Genome for Mutations Clin. Chem., November 1, 2002; 48(11): 1901 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohkubo, A. Yamano, M. Nagashima, Y. Mori, K. Anzai, Y. Akehi, R. Nomiyama, T. Asano, A. Urae, and J. Ono Mitochondrial Gene Mutations in the tRNALeu(UUR) Region and Diabetes: Prevalence and Clinical Phenotypes in Japan Clin. Chem., September 1, 2001; 47(9): 1641 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. E.A. Pesch, B. Leo-Kottler, S. Mayer, B. Jurklies, U. Kellner, E. Apfelstedt-Sylla, E. Zrenner, C. Alexander, and B. Wissinger OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance Hum. Mol. Genet., June 1, 2001; 10(13): 1359 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lodi, P. Montagna, P. Cortelli, S. Iotti, S. Cevoli, V. Carelli, and B. Barbiroli `Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation Brain, September 1, 2000; 123(9): 1896 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Awadalla, A. Eyre-Walker, and J. M. Smith Linkage Disequilibrium and Recombination in Hominid Mitochondrial DNA Science, December 24, 1999; 286(5449): 2524 - 2525. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Tsao, P. A Aitken, and D. R Johns Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy Br. J. Ophthalmol., May 1, 1999; 83(5): 577 - 581. [Abstract] [Full Text]
|
|
|
|
|
|
R. M Andrews, P. G Griffiths, M. A Johnson, and D. M Turnbull Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina Br. J. Ophthalmol., February 1, 1999; 83(2): 231 - 235. [Abstract] [Full Text]
|
|
|
|
|
|
M. Chee, R. Yang, E. Hubbell, A. Berno, X. C. Huang, D. Stern, J. Winkler, D. J. Lockhart, M. S. Morris, and S. P. A. Fodor Accessing Genetic Information with High-Density DNA Arrays Science, October 25, 1996; 274(5287): 610 - 614. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Hirano and S. G. Pavlakis Topical Review: Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes (MELAS): Current Concepts J Child Neurol, January 1, 1994; 9(1): 4 - 13. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
